[go: up one dir, main page]

HK1127041A - Azetidinone derivatives for the treatment of disorders of the lipid metabolism - Google Patents

Azetidinone derivatives for the treatment of disorders of the lipid metabolism Download PDF

Info

Publication number
HK1127041A
HK1127041A HK09106243.3A HK09106243A HK1127041A HK 1127041 A HK1127041 A HK 1127041A HK 09106243 A HK09106243 A HK 09106243A HK 1127041 A HK1127041 A HK 1127041A
Authority
HK
Hong Kong
Prior art keywords
lipid metabolism
disorders
treatment
azetidinone
azetidinone derivatives
Prior art date
Application number
HK09106243.3A
Other languages
Chinese (zh)
Inventor
G. Aslanian Robert
E. Bennett Chad
A. Burnett Duane
Chan Tin-Yau
Y. Kiselgof Eugenia
E. Knutson Chad
M. Harris Joel
A. MC KITTRICK Brian
Palani Anandan
M. Smith Elizabeth
M. Vaccaro Henry
Xiao Dong
M. KIM Hyunjin
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of HK1127041A publication Critical patent/HK1127041A/en

Links

Abstract

The present invention relates to Azetidinone Derivatives, compositions comprising an Azetidinone Derivative and methods for treating or preventing a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease, comprising administering to a patient an effective amount of an Azetidinone Derivative.
HK09106243.3A 2006-09-15 2007-09-13 Azetidinone derivatives for the treatment of disorders of the lipid metabolism HK1127041A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/845,075 2006-09-15

Publications (1)

Publication Number Publication Date
HK1127041A true HK1127041A (en) 2009-09-18

Family

ID=

Similar Documents

Publication Publication Date Title
WO2008033464A3 (en) Azetidinone derivatives for the treatment of disorders of the lipid metabolism
MX2009002924A (en) Spirocyclic azetidinone derivatives for the treatment of disorders of lipid metabolism, pain, diabetes and other disorders.
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
WO2008033460A3 (en) Treating pain, diabetes, and lipid metabolism disorders
WO2006078463A3 (en) Method for treating cardiovascular disease
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
WO2008089307A3 (en) Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer
WO2007061661A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2007130383A3 (en) Compositions and treatments using pyridazine compounds and secretases
WO2006108582A3 (en) Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis
WO2007127474A3 (en) Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
EA200900940A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PYRAZOL-O-GLUCOSIDE DERIVATIVE
WO2005116002A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200740452A (en) Therapeutic gastrodia extracts
WO2006062748A3 (en) Omega-3 fatty acids and dyslipidemic agent for lipid therapy
WO2007002516A3 (en) Improved dosage forms for movement disorder treatment
EP2985281A3 (en) Isoindoline compounds for use in the treatment of cancer
WO2008082602A3 (en) Compounds and pharmaceutical compositions for the treatment of liver disorders
MX2010001560A (en) Pharmaceutical composition comprising a sglt2 inhibitor in combination with a dpp-iv inhibitor.
WO2001009118A3 (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
MX2010001696A (en) Pharmaceutical composition comprising a glucopyranosyl-substitute d benzene derivative.
WO2008157537A3 (en) Compositions and methods of use for treating or preventing lipid related disorders
WO2005051429A3 (en) Targeted conjugates with a modified saccharide linker